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Cancer is a group of diseases characterized by the uncontrolled, abnormal growth 
of cells. Anticancer chemotherapy is one of the basic methods for treatment, but its 
mechanism of action is not specific and targets rapidly dividing cells, including 
cancer cells as well as certain normal tissues. In recent years one of the most studied 
ways to improve cancer treatment is inhibition of DNA repair mechanisms. This 
process can lead to potentially higher efficacy of cytotoxic therapy and thus lower 
doses of cytostatic agents with benefit of less adverse side effects for the patient. 
Suitable candidate for this purpose is family of phosphatidylinositol 3-kinase-
related protein kinases (PIKK). 
In this diploma thesis, sixteen purine analogs of nonselective inhibitor PIKK 
LY294002 were prepared. We also analyzed chemo-sensitizing properties of these 
newly synthesized inhibitors in combination with a chemotherapeutic agent 
doxorubicin in 9 human cancerous and 1 non-cancerous cell lines. Two inhibitors 
have chemo-sensitizing effect on most cancer cell lines and may have therapeutic 
potential for the treatment of patient with cancer.  
 
